市场调查报告书

羟氯喹:全球市场的展望(2018-2027年)

Hydroxychloroquine - Global Market Outlook (2018-2027)

出版商 Stratistics Market Research Consulting 商品编码 939095
出版日期 内容资讯 英文 140 Pages
商品交期: 2-3个工作天内
价格
羟氯喹:全球市场的展望(2018-2027年) Hydroxychloroquine - Global Market Outlook (2018-2027)
出版日期: 2020年05月01日内容资讯: 英文 140 Pages
简介

全球羟氯喹的市场在预测期间内预计将以10.4%的年复合成长率推移,从2018年的4130万美元,成长到2027年1亿62万美元的规模。老年人口的增加,及第三世界的国家疟疾用药物高需求等要素促进了该市场的成长。可是同时,产品的回收和制造销售的中止等要素阻碍了市场进一步成长。

本报告提供全球羟氯喹的市场调查,汇整市场及产品概要,市场成长的各种影响因素及市场机会分析,各类型·投药途径·等级·成分·用途·地区/主要国家等各种区分趋势与市场规模的变化与预测,竞争环境,主要企业简介等资讯。

第1章 摘要整理

第2章 序文

第3章 市场趋势分析

  • 简介
  • 促进因素
  • 阻碍因素
  • 市场机会
  • 威胁
  • 用途分析
  • 新兴市场
  • Covid-19的影响

第4章 波特的五力分析

第5章 全球羟氯喹市场:各类型

  • 简介
  • 平板电脑
  • 注射剂

第6章 全球羟氯喹市场:各给药途径

  • 简介
  • 口服
  • 静脉内注射

第7章 全球羟氯喹市场:各等级

  • 简介
  • 美国药典条约(USP)标准等级
  • 医药品规格等级
  • 欧洲药典(EP)标准等级

第8章 全球羟氯喹市场:各成分

  • 简介
  • 100 mg
  • 200 mg
  • 250 mg
  • 400 mg
  • 500 mg
  • 800 mg

第9章 全球羟氯喹市场:各销售管道

  • 简介
  • 院内药局
  • 线上药局
  • 专门药局
  • 零售药局
  • 顺势疗法

第10章 全球羟氯喹市场:各用途

  • 简介
  • 疟疾
  • 类风湿性关节炎
  • 红斑
    • 全身性红斑性狼疮
  • 皮肤病变
  • COVID-19(新型冠状病毒感染疾病)

第11章 全球羟氯喹市场: 各地区

  • 简介
  • 北美
  • 欧洲
  • 亚太地区
  • 南美
  • 中东·非洲

第12章 主要展开

  • 契约·联盟·合作·JV
  • M&A
  • 新产品的销售
  • 扩张
  • 其他主要策略

第13章 企业简介

  • Hikma Pharmaceuticals PLC
  • Cadila Healthcare Ltd
  • Ipca Laboratories Ltd
  • Novartis AG
  • Mylan N.V
  • Sanofi S.A
  • Taj Pharmaceuticals Ltd
  • Shanghai Pharmaceuticals Holding Co., Ltd
  • Torrent Pharmaceuticals Ltd
  • Teva Pharmaceutical Industries Ltd
  • Dr. Reddy's Laboratories Ltd
  • Sun Pharmaceutical Industries Ltd
  • Zydus Cadila
目录

According to Stratistics MRC, the Global Hydroxychloroquine Market is accounted for $41.30 million in 2018 and is expected to reach $100.62 million by 2027 growing at a CAGR of 10.4% during the forecast period. The rising geriatric population, and the high demand for the drug from third world nations for dealing with malarial are the major factors propelling the market growth. However, factors such as product recalls and discontinuation of drugs are hampering the market growth.

Hydroxychloroquine is a medication and analogue of chloroquine. It has antirheumatic as well as antimalarial properties. It has been used widely for the treatment of infectious as well as rheumatoid arthritis. It has been recognized that clinical use of hydroxychloroquine has significantly improve the treatment rate of patient suffering from the COVID-19. The growth of hydroxychloroquine enhanced by the growing cases of infectious diseases that majorly includes coronavirus and malaria and increase research and development activities. In addition, advances in the treatment options and presence of well-established healthcare facilities are some of the impacting factors for the demand of hydroxychloroquine drugs.

Based on the application, the COVID-19 segment is going to have a lucrative growth during the forecast period as this is a new condition and a large number of trials are conducted on the effectiveness of the medicine in treating the condition, it would contribute to the growth rate witnessed by this segment. The fact that a large number of patients with COVID-19 are admitted to hospitals for treatment results in high preference and dependence on this medicine, contributing to the market share held by this segment.

By geography, Asia Pacific is going to have a lucrative growth during the forecast period attributed to India being the leading producer of the drug and China being the largest exporter of the raw materials for the drug production. Apart from this, it is cost-effective drug in India costing nearly lesser than rupees three per tablet. Moreover, the drug has been advocated in countries like India as a measure to prevent the coronavirus in people who have been in contact with COVID positive persons and those falling in high risk zone. All these aforementioned aspects are likely to favorably leverage the growth of the Hydroxychloroquine market over the forecast period.

Some of the key players profiled in the Hydroxychloroquine Market include Hikma Pharmaceuticals PLC, Cadila Healthcare Ltd, Ipca Laboratories Ltd, Novartis AG , Mylan N.V, Sanofi S.A, Taj Pharmaceuticals Ltd , Shanghai Pharmaceuticals Holding Co., Ltd, Torrent Pharmaceuticals Ltd, Teva Pharmaceutical Industries Ltd , Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Ltd, and Zydus Cadila.

Types Covered:

  • Tablets
  • Injection

Route of Administrations Covered:

  • Oral
  • Intravenous

Grades Covered:

  • United States Pharmacopeial Convention (USP) Standards Grade
  • Pharmaceutical Standards Grade
  • European Pharmacopoeia (EP) Standards Grade

Strengths Covered:

  • 100 mg
  • 200 mg
  • 250 mg
  • 400 mg
  • 500 mg
  • 800 mg

Distribution Channels Covered:

  • Hospital Pharmacy
  • Online Pharmacy
  • Speciality Drug Stores
  • Retail Pharmacy
  • Homeocare

Applications Covered:

  • Malaria
  • Rheumatoid arthritis
  • Lupus Erythematosus
  • Skin Lesions
  • COVID-19

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking

Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Hydroxychloroquine Market, By Type

  • 5.1 Introduction
  • 5.2 Tablets
  • 5.3 Injection

6 Global Hydroxychloroquine Market, By Route of Administration

  • 6.1 Introduction
  • 6.2 Oral
  • 6.3 Intravenous

7 Global Hydroxychloroquine Market, By Grade

  • 7.1 Introduction
  • 7.2 United States Pharmacopeial Convention (USP) Standards Grade
  • 7.3 Pharmaceutical Standards Grade
  • 7.4 European Pharmacopoeia (EP) Standards Grade

8 Global Hydroxychloroquine Market, By Strength

  • 8.1 Introduction
  • 8.2 100 mg
  • 8.3 200 mg
  • 8.4 250 mg
  • 8.5 400 mg
  • 8.6 500 mg
  • 8.7 800 mg

9 Global Hydroxychloroquine Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Hospital Pharmacy
  • 9.3 Online Pharmacy
  • 9.4 Speciality Drug Stores
  • 9.5 Retail Pharmacy
  • 9.6 Homeocare

10 Global Hydroxychloroquine Market, By Application

  • 10.1 Introduction
  • 10.2 Malaria
  • 10.3 Rheumatoid arthritis
  • 10.4 Lupus Erythematosus
    • 10.4.1 Systemic Lupus Erythematosus
    • 10.4.2 Chronic Discoid Lupus Erythematosus
  • 10.5 Skin Lesions
  • 10.6 COVID-19

11 Global Hydroxychloroquine Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Hikma Pharmaceuticals PLC
  • 13.2 Cadila Healthcare Ltd
  • 13.3 Ipca Laboratories Ltd
  • 13.4 Novartis AG
  • 13.5 Mylan N.V
  • 13.6 Sanofi S.A
  • 13.7 Taj Pharmaceuticals Ltd
  • 13.8 Shanghai Pharmaceuticals Holding Co., Ltd
  • 13.9 Torrent Pharmaceuticals Ltd
  • 13.10 Teva Pharmaceutical Industries Ltd
  • 13.11 Dr. Reddy's Laboratories Ltd
  • 13.12 Sun Pharmaceutical Industries Ltd
  • 13.13 Zydus Cadila

List of Tables

  • Table 1 Global Hydroxychloroquine Market Outlook, By Region (2017-2027) ($MN)
  • Table 2 Global Hydroxychloroquine Market Outlook, By Type (2017-2027) ($MN)
  • Table 3 Global Hydroxychloroquine Market Outlook, By Tablets (2017-2027) ($MN)
  • Table 4 Global Hydroxychloroquine Market Outlook, By Injection (2017-2027) ($MN)
  • Table 5 Global Hydroxychloroquine Market Outlook, By Route of Administration (2017-2027) ($MN)
  • Table 6 Global Hydroxychloroquine Market Outlook, By Oral (2017-2027) ($MN)
  • Table 7 Global Hydroxychloroquine Market Outlook, By Intravenous (2017-2027) ($MN)
  • Table 8 Global Hydroxychloroquine Market Outlook, By Grade (2017-2027) ($MN)
  • Table 9 Global Hydroxychloroquine Market Outlook, By United States Pharmacopeial Convention (USP) Standards Grade (2017-2027) ($MN)
  • Table 10 Global Hydroxychloroquine Market Outlook, By Pharmaceutical Standards Grade (2017-2027) ($MN)
  • Table 11 Global Hydroxychloroquine Market Outlook, By European Pharmacopoeia (EP) Standards Grade (2017-2027) ($MN)
  • Table 12 Global Hydroxychloroquine Market Outlook, By Strength (2017-2027) ($MN)
  • Table 13 Global Hydroxychloroquine Market Outlook, By 100 mg (2017-2027) ($MN)
  • Table 14 Global Hydroxychloroquine Market Outlook, By 200 mg (2017-2027) ($MN)
  • Table 15 Global Hydroxychloroquine Market Outlook, By 250 mg (2017-2027) ($MN)
  • Table 16 Global Hydroxychloroquine Market Outlook, By 400 mg (2017-2027) ($MN)
  • Table 17 Global Hydroxychloroquine Market Outlook, By 500 mg (2017-2027) ($MN)
  • Table 18 Global Hydroxychloroquine Market Outlook, By 800 mg (2017-2027) ($MN)
  • Table 19 Global Hydroxychloroquine Market Outlook, By Distribution Channel (2017-2027) ($MN)
  • Table 20 Global Hydroxychloroquine Market Outlook, By Hospital Pharmacy (2017-2027) ($MN)
  • Table 21 Global Hydroxychloroquine Market Outlook, By Online Pharmacy (2017-2027) ($MN)
  • Table 22 Global Hydroxychloroquine Market Outlook, By Speciality Drug Stores (2017-2027) ($MN)
  • Table 23 Global Hydroxychloroquine Market Outlook, By Retail Pharmacy (2017-2027) ($MN)
  • Table 24 Global Hydroxychloroquine Market Outlook, By Homeocare (2017-2027) ($MN)
  • Table 25 Global Hydroxychloroquine Market Outlook, By Application (2017-2027) ($MN)
  • Table 26 Global Hydroxychloroquine Market Outlook, By Malaria (2017-2027) ($MN)
  • Table 27 Global Hydroxychloroquine Market Outlook, By Rheumatoid arthritis (2017-2027) ($MN)
  • Table 28 Global Hydroxychloroquine Market Outlook, By Lupus Erythematosus (2017-2027) ($MN)
  • Table 29 Global Hydroxychloroquine Market Outlook, By Systemic Lupus Erythematosus (2017-2027) ($MN)
  • Table 30 Global Hydroxychloroquine Market Outlook, By Chronic Discoid Lupus Erythematosus (2017-2027) ($MN)
  • Table 31 Global Hydroxychloroquine Market Outlook, By Skin Lesions (2017-2027) ($MN)
  • Table 32 Global Hydroxychloroquine Market Outlook, By COVID-19 (2017-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.